Cigna Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -48.1% | +229.9% | -94.5% | -82.6% | +11,230.4% | -63.2% | -198.2% | – | +79.9% | -81.6% | -137.2% | – | |
| – | -0.1% | -3.1% | -0.4% | -11.9% | -0.6% | +4.3% | +1.2% | +2.2% | +3.6% | -10.0% | +0.8% | – | |
| – | -80.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -183.5% | – | -180.3% | – | – | -96.9% | -4,526.1% | – | +329.7% | -139.1% | – | – | |
| – | -9.4% | -17.8% | +23.3% | +7.8% | -15.5% | -3.0% | -12.8% | -2.5% | +15.8% | -17.1% | +11.2% | – | |
| – | -67.1% | +12.5% | +29.3% | +21.2% | -75.4% | – | -166.6% | +450.4% | -90.4% | +51.7% | -21.0% | – | |
| – | -1.1% | +12.0% | -2.2% | -0.5% | -1.5% | +7.3% | -2.7% | +0.2% | -1.5% | +5.3% | -1.9% | – | |
| – | -12.8% | +639.3% | -75.4% | +377.7% | -57.2% | -25.4% | -26.3% | +119.6% | -59.0% | -100.0% | – | – | |
| – | – | – | – | – | -192.2% | +107.2% | – | +1,017.1% | -180.1% | -78.1% | – | – | |
| – | -51.4% | +102.3% | -8.7% | – | -839.9% | +13.3% | -63.8% | – | -252.9% | -71.9% | – | – | |
| – | – | – | -248.7% | – | – | -131.8% | – | – | -2.7% | -139.7% | – | – | |
| – | -54.5% | +312.0% | -102.3% | – | – | -67.3% | -236.3% | – | +85.6% | -85.2% | -183.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.